Literature DB >> 7534889

Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy.

I Brindel1, J L Preud'homme, J M Vallat, D Vincent, J L Vasquez, M O Jauberteau.   

Abstract

A possibly pathogenic serum monoclonal IgM lambda from a patient with chronic relapsing polyneuropathy was shown to react with the disialosyl-lactosyl residue (NeuAc alpha 2-8NeuAc alpha 2-3) -Gal beta 1-4Glc expressed by GD1b, GT1b, GQ1b, GD2 and GD3. A part of this epitope in terminal position in GM3, GD1a and LM1 was also recognized by the IgM lambda.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534889     DOI: 10.1016/0304-3940(94)90570-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

Review 1.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  Antibodies against disialosyl and terminal NeuNAc(alpha2-3)Gal ganglioside epitopes in acute relapsing sensory ataxic neuropathy.

Authors:  Ricard Rojas-Garcia; Eduard Gallardo; Monica Povedano; Noemi de Luna; Jordi Bruna; Candido Juarez; Jordi Diaz-Manera; Juan Antonio Martinez-Matos; Isabel Illa
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

Review 3.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Characterization of the Antibody Response after Cervical Spinal Cord Injury.

Authors:  Antigona Ulndreaj; Apostolia Tzekou; Andrea J Mothe; Ahad M Siddiqui; Rachel Dragas; Charles H Tator; Emina E Torlakovic; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2016-12-21       Impact factor: 5.269

5.  A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

Authors:  H J Willison; G M O'Hanlon; G Paterson; J Veitch; G Wilson; M Roberts; T Tang; A Vincent
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.